7Baggers

Kura Oncology, Inc
(NASDAQ:KURA) 

KURA stock logo

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor ...

Founded: 2014
Full Time Employees: 83
CEO / Co-Founder: Troy Wilson 
Sector: Healthcare
Industry: Biotechnology
PharmaceuticalsOncology
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 
                                                       
      revenue
    		                                                   
      yoy
    		                                                   
      qoq
    		                                                   
      product revenue
    		5,766,000                                                   
      collaboration revenue
    		12,499,000 15,204,000 20,750,000 15,288,000 14,108,000                                               
      total revenue
    		18,265,000 17,336,000 20,750,000 15,288,000 14,108,000                                               
      operating expenses
    		                                                   
      cost of product sales
    		262,000                                                   
      research and development
    		65,263,000 64,408,000 67,908,000 62,785,000 55,973,000 52,267,000 41,705,000 39,727,000 36,268,000 32,533,000 29,328,000 28,182,000 25,192,000 22,668,000 24,973,000 24,258,000 20,913,000 20,956,000 22,367,000 21,074,000 20,324,000 17,524,000 16,601,000 13,697,000 12,575,000 13,748,000 12,407,000 11,342,000 10,329,000 11,920,000 11,480,000 11,099,000 11,267,000 7,928,000 6,808,000 5,158,000 5,220,000 4,744,000 4,305,000 3,959,000 3,567,000 4,314,000 3,642,000 3,345,000 2,604,000       
      selling, general and administrative
    		31,555,000                                                   
      total operating expenses
    		97,080,000 103,604,000 100,747,000 87,954,000 78,808,000 76,338,000 59,884,000 56,404,000 54,452,000 46,762,000 42,473,000 40,003,000 36,566,000 35,156,000 36,594,000 35,333,000 32,782,000 33,038,000 33,677,000 33,647,000 30,896,000 26,332,000 24,194,000 21,173,000 20,200,000 18,963,000 17,674,000 15,891,000 14,951,000 16,634,000 15,982,000 15,276,000 14,991,000 10,995,000 9,499,000 7,930,000 7,653,000 7,478,000 7,058,000 6,791,000 7,040,000 6,842,000 6,428,000 5,907,000 4,688,000       
      income from operations
    		-78,815,000 -86,268,000 -79,997,000 -72,666,000 -64,700,000                                               
      yoy
    		21.82%                                                   
      qoq
    		-8.64% 7.84% 10.09% 12.31%                                                
      operating margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%       
      other income
    		                                                   
      interest and other income
    		5,826,000 5,686,000 6,274,000 6,935,000 7,879,000 5,659,000 5,892,000 5,973,000 5,325,000 4,370,000 4,275,000 3,216,000 2,861,000 2,271,000 1,090,000 564,000 329,000 295,000 311,000 290,000                                
      interest expense
    		-336,000 -346,000 -393,000 -391,000 -382,000 -403,000 -412,000 -406,000 -398,000 -394,000 -404,000 -387,000 -364,000       -306,000 -108,000 -144,000 -146,000 -144,000 -144,000 -142,000 -145,000 -148,000 -145,000 -193,000 -252,000 -267,000 -258,000 -250,000 -226,000 -209,000 -203,000 -194,000 -194,000 -189,000     -42,000       
      total other income
    		5,490,000 5,340,000 5,881,000 6,544,000 7,497,000 5,256,000 5,480,000 5,567,000 4,927,000 3,976,000 3,871,000 2,829,000 2,497,000 2,042,000 1,090,000 564,000 329,000 295,000 311,000 -16,000 202,000 173,000 425,000 686,000 990,000 1,098,000 1,282,000 948,000 1,011,000 537,000 975,000 537,000 387,000 247,000 166,000 110,000 120,000 131,000 132,000 130,000 414,000 368,000 338,000 322,000 212,000       
      income before income taxes
    		-73,325,000 -80,928,000 -74,116,000 -66,122,000 -57,203,000                                               
      income tax expense
    		8,000 71,000   226,000                                               
      net income
    		-73,333,000 -80,999,000 -74,116,000 -66,122,000 -57,429,000 -19,217,000 -54,404,000 -50,837,000 -49,525,000 -42,786,000 -38,602,000 -37,174,000 -34,069,000 -33,114,000 -35,504,000 -34,769,000 -32,453,000 -32,743,000 -33,366,000 -33,663,000 -30,694,000 -26,159,000 -23,769,000 -20,487,000 -19,210,000 -17,865,000 -16,392,000 -14,943,000 -13,940,000 -16,097,000 -15,007,000 -14,739,000 -14,604,000 -10,748,000 -9,333,000 -7,820,000 -7,533,000 -7,347,000 -6,926,000 -6,661,000 -6,626,000 -6,474,000 -6,090,000 -5,585,000        
      yoy
    		27.69% 321.50% 36.23% 30.07% 15.96% -55.09% 40.94% 36.75% 45.37% 29.21% 8.73% 6.92% 4.98% 1.13% 6.41% 3.29% 5.73% 25.17% 40.38% 64.31% 59.78% 46.43% 45.00% 37.10% 37.80% 10.98% 9.23% 1.38% -4.55% 49.77% 60.80% 88.48% 93.87% 46.29% 34.75% 17.40% 13.69% 13.48% 13.73% 19.27%            
      qoq
    		-9.46% 9.29% 12.09% 15.14% 198.84% -64.68% 7.02% 2.65% 15.75% 10.84% 3.84% 9.11% 2.88% -6.73% 2.11% 7.14% -0.89% -1.87% -0.88% 9.67% 17.34% 10.06% 16.02% 6.65% 7.53% 8.99% 9.70% 7.20% -13.40% 7.26% 1.82% 0.92% 35.88% 15.16% 19.35% 3.81% 2.53% 6.08% 3.98% 0.53% 2.35% 6.31% 9.04%         
      net income margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN%       
      net income per share
    		-0.83 -0.92 -0.85 -0.75 -0.66 -0.22 -0.63 -0.59 -0.59 -0.55 -0.5 -0.53 -0.5 -0.49 -0.53 -0.52 -0.49 -0.5 -0.5 -0.51 -0.46 -0.45 -0.42 -0.4 -0.42 -0.4 -0.36 -0.38 -0.37 -0.42 -0.4 -0.45 -0.46 -0.36 -0.38 -0.4 -0.39 -0.38 -0.37 -0.36 -0.36 -0.3 -0.57 -0.54 -1.41       
      weighted-average number of shares used in computing net loss per share, basic and diluted
    		88,610 87,676 87,645 87,586 87,415 86,161 86,950 86,635 83,905 73,229 77,241 69,795 68,403 66,990 66,889 66,672 66,607 66,352 66,353 66,282 66,218 53,077 56,405 51,633 45,411 41,946 45,241 38,928 38,168 35,191 37,789 32,971 31,829 23,237 24,344 19,789 19,464 18,701 18,850 18,548 18,245 9,933 10,723 10,420 3,184       
      comprehensive loss
    		-74,737 -80,893 -73,909 -66,385 -57,219 -19,569 -52,825 -50,484 -49,070 -40,522 -36,915 -36,500 -31,933 -31,730 -37,105 -35,936 -37,312 -34,338 -33,167 -33,974 -30,822 -26,337 -24,102 -20,491 -18,980 -17,866 -16,221 -14,800 -13,791 -16,105 -15,037 -14,764 -14,623 -10,783 -9,325 -7,823 -7,534 -7,376 -6,960 -6,627 -6,528 -6,562 -6,075 -5,599        
      other comprehensive income
    		                             -18.5 -30                     
      unrealized gain on short-term investments
    		-1,404 106 207 -263 210                                               
      general and administrative
    		 20,210,750 32,839,000 25,169,000 22,835,000 24,071,000 18,179,000 16,677,000 18,184,000 14,229,000 13,145,000 11,821,000 11,374,000 12,488,000 11,621,000 11,075,000 11,869,000 12,082,000 11,310,000 12,573,000 10,572,000 8,808,000 7,593,000 7,476,000 7,625,000 5,761,000 5,047,000 4,363,000 4,482,000 4,470,000 4,251,000 3,736,000 3,366,000 2,799,000 2,313,000 2,217,000 2,075,000 1,941,000 1,717,000 1,838,000 2,365,000 1,711,000 1,779,000 1,492,000 1,037,000       
      operating expenses:
    		                                                   
      other income:
    		                                                   
      comprehensive loss:
    		                                                   
      other comprehensive income:
    		                                                   
      unrealized gain on marketable securities
    		     596.75 1,579 353 455                 115.75 171 143 149     -35 8 -3 -1 -29 -34 34 98 0.25 15         
      unrealized gain on marketable securities and foreign currency
    		         2,264 1,687 674 2,136 -1,906.75 -1,601   -1,595 199 -311 -128 -178 -333 -4 230                           
      other comprehensive loss:
    		                                                   
      unrealized loss on marketable securities and foreign currency
    		               -1,167 -4,859                                   
      management fee income, related party
    		                    8,000 12,000 12,000 12,000 15,000 14,000 31,000 74,000 126,000 180,000 180,000 180,000 195,000 195,000 195,000 195,000 195,000 195,000 195,000 195,000 300,000 300,000 300,000 300,000 300,000       
      interest income
    		                    302,000 305,000 559,000 818,000 1,119,000 1,226,000 1,396,000 1,022,000 1,030,000 1,048,000 1,047,000 624,000 450,000 302,000 197,000 124,000 128,000 130,000 131,000 124,000 114,000 68,000 38,000 22,000        
      research and development, related party
    		                         71,000 133,000 98,000 53,000 164,000 181,000 377,000 299,000 191,000 334,000 494,000 293,000 759,000 1,011,000 977,000 1,082,000 799,000 993,000 1,056,000 1,024,000       
      general and administrative, related party
    		                         65,500 87,000 88,000 87,000 80,000 70,000 64,000 59,000 77,000 44,000 61,000 65,000 34,000 25,000 17,000 26,000 18,000 14,000 14,000 23,000       
      other comprehensive loss
    		                               -25 -19                   
      interest expense, related party
    		                                            -46,000       
      unrealized loss on marketable securities
    		                                           -14        
      net loss and comprehensive loss
    		                                            -4,476,000       
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 
                                                                            
        assets
      		                                                                      
        current assets
      		                                                                      
        cash and cash equivalents
      		39,083,000 149,099,000 95,287,000 81,948,000 51,269,000 224,462,000 49,480,000 45,183,000 41,506,000 37,318,000 28,740,000 49,124,000 27,059,000 51,802,000 90,937,000 39,257,000 33,832,000 90,672,000 39,183,000 38,974,000 110,835,000 325,493,000 76,955,000 134,758,000 33,811,000 26,135,000 54,742,000 122,080,000 17,778,000 16,119,000 20,568,000 17,658,000 26,518,000 11,433,000 23,336,000 12,154,000 10,642,000 9,725,000 6,783,000 12,112,000 16,326,000 15,443,000 11,215,000 19,788,000  5,613 18,217 4,918 6,168 6,568 10,580 18,705 2,901 4,802 5,586 9,481 23,743 4,220 6,155 9,255 24,634 26,898 5,760 10,995 11,142 13,031 16,775 7,408 7,508 9,284 
        short-term investments
      		541,740,000 518,141,000 454,378,000 548,780,000 606,922,000 502,933,000 405,817,000 446,336,000 485,616,000 386,639,000 423,853,000 427,855,000 378,841,000 386,183,000 336,838,000 411,001,000 446,243,000 427,288,000 504,262,000 528,520,000 493,038,000 307,827,000 248,458,000 204,111,000 183,124,000 210,756,000 195,384,000 139,333,000 147,747,000 162,866,000 166,855,000 108,227,000 111,682,000 81,712,000 77,469,000 41,090,000 48,511,000 58,065,000 67,785,000 67,978,000 62,140,000 70,303,000 30,017,000 26,145,000                           
        accounts receivable
      		9,348,000 8,804,000                                                                     
        inventory
      		843,000 413,000                                                                     
        prepaid expenses and other current assets
      		32,768,000 32,206,000 35,062,000 24,773,000 17,261,000 17,434,000 7,892,000 8,249,000 10,713,000 8,524,000 7,324,000 8,667,000 10,550,000 8,441,000 8,616,000 9,528,000 6,959,000 4,329,000 5,460,000 6,138,000 6,832,000 3,972,000 3,498,000 3,317,000 4,164,000 2,682,000 2,775,000 2,380,000 1,882,000 1,988,000 2,737,000 2,420,000 1,904,000 1,280,000 909,000 1,187,000 1,134,000 725,000 886,000 1,045,000 1,203,000 693,000 695,000 884,000                           
        total current assets
      		623,782,000 708,663,000 620,663,000 660,075,000 724,198,000 744,829,000 463,189,000 499,768,000 537,835,000 432,481,000 459,917,000 485,646,000 416,450,000 446,426,000 436,391,000 459,786,000 487,034,000 522,289,000 548,905,000 573,632,000 610,705,000 637,292,000 328,911,000 342,186,000 221,130,000 239,603,000 252,948,000 263,904,000 167,586,000 181,197,000 190,392,000 128,535,000 140,361,000 94,641,000 101,923,000 54,735,000 60,628,000 68,810,000 75,715,000 81,421,000 80,075,000 86,869,000 42,306,000 47,189,000 54,627,000                          
        property and equipment
      		7,613,000 7,855,000 7,397,000 3,912,000 2,348,000 1,682,000 1,315,000 1,523,000 1,709,000 1,859,000 2,057,000 2,253,000 2,370,000 2,540,000 2,734,000 2,546,000 2,567,000 2,673,000 2,731,000 2,300,000 2,069,000 2,021,000 2,103,000 1,652,000 805,000 44,000      1,000 5,000 10,000 17,000 24,000 32,000 40,000 47,000 55,000 62,000 71,000 78,000 59,000 34,000                          
        operating lease right-of-use assets
      		7,166,000 7,302,000 7,539,000 7,864,000 8,139,000 5,803,000 6,100,000 6,400,000 6,698,000 6,993,000 7,281,000 2,933,000 3,391,000 3,842,000 4,284,000 4,719,000 5,149,000 5,573,000 5,989,000 5,443,000 5,949,000 6,334,000 6,711,000 7,108,000                                               
        other long-term assets
      		13,990,000 14,543,000 13,782,000 10,574,000 9,079,000 7,845,000 8,233,000 7,425,000 7,666,000 7,602,000 4,516,000 3,695,000 3,554,000 3,288,000 4,369,000 4,164,000 3,625,000 3,306,000 3,306,000 3,306,000 1,330,000 1,355,000 1,632,000 1,844,000 4,317,000 2,325,000 1,517,000 1,587,000 1,772,000 1,182,000 1,108,000 1,091,000 1,092,000 1,200,000 1,175,000 1,088,000 1,259,000 971,000 542,000 268,000 240,000 314,000 438,000 279,000 150,000                          
        total assets
      		652,551,000 738,363,000 649,381,000 682,425,000 743,764,000 760,159,000 478,837,000 515,116,000 553,908,000 448,935,000 473,771,000 494,737,000 425,975,000 456,306,000 447,988,000 471,425,000 498,585,000 534,051,000 561,141,000 584,891,000 620,263,000 647,212,000 339,567,000 353,000,000 226,462,000 241,972,000 254,602,000 265,685,000 169,617,000 182,379,000 191,500,000 129,627,000 141,458,000 95,851,000 103,115,000 55,847,000 61,919,000 69,821,000 76,304,000 81,744,000 80,382,000 87,259,000 42,827,000 47,532,000 54,816,000 5,613 18,217 4,918 6,793 9,068 14,955 18,705 4,026 8,302 11,461 15,731 24,368 6,720 10,530 15,505 25,259 29,398 11,385 10,995 13,017 16,031 21,275 7,408 7,508 12,284 
        liabilities and stockholders’ equity
      		                                                                      
        current liabilities
      		                                                                      
        accounts payable
      		7,043,000 5,017,000               1,337,000                             2,402 10,682 8,155 713 350 650 175 6,290 1,850 633 175 3,816 2,927 2,497 2,200           
        accrued expenses and other current liabilities
      		45,466,000 61,697,000                                                                     
        current operating lease liabilities
      		1,283,000 1,277,000 1,429,000 1,696,000 1,905,000 1,881,000 1,691,000 1,467,000 1,363,000 1,506,000 1,682,000 2,345,000 2,332,000 2,318,000 2,304,000 2,290,000 2,276,000                                                      
        current portion of contract liabilities
      		47,704,000 48,983,000 48,750,000 49,435,000 40,846,000 24,271,000                                                                 
        total current liabilities
      		101,496,000 116,974,000 121,304,000 107,174,000 89,766,000 78,712,000 40,372,000 33,451,000 32,266,000 35,263,000 27,525,000 23,899,000 19,233,000 24,057,000 24,745,000 17,873,000 17,725,000 22,455,000 21,926,000 21,290,000 25,139,000 26,024,000 21,705,000 18,551,000 14,554,000 15,564,000 13,112,000 11,232,000 12,143,000 13,615,000 12,905,000 12,580,000 11,351,000 10,031,000 7,562,000 5,076,000 4,116,000 5,451,000 5,272,000 4,384,000 4,310,000 5,055,000 4,711,000 3,604,000 5,531,000                          
        long-term debt
      		9,749,000 9,711,000 5,336,000 6,509,000 7,650,000 6,916,000 7,757,000 8,576,000 9,376,000 9,332,000 9,289,000 9,244,000 9,200,000 9,158,000       3,500,000 4,250,000 5,000,000 5,750,000 6,500,000 7,250,000 7,500,000 7,500,000 7,500,000 7,500,000 3,432,000 4,150,000 4,861,000 5,567,000 6,018,000 6,855,000 7,339,000 7,324,000 7,308,000 7,292,000                               
        long-term operating lease liabilities
      		13,241,000 9,469,000 8,364,000 8,156,000 7,878,000 5,190,000 5,466,000 5,843,000 6,231,000 6,362,000 6,453,000 1,455,000 2,008,000 2,548,000 3,080,000 3,602,000 4,114,000 4,612,000 5,103,000 4,755,000 5,196,000 5,638,000                                                 
        other long-term liabilities
      		3,437,000 3,165,000 2,981,000 2,595,000 2,139,000 1,795,000 1,471,000 1,176,000 951,000 705,000 567,000 461,000 351,000 265,000 542,000 459,000 496,000 375,000 356,000 295,000 441,000 395,000 344,000 306,000 2,207,000 377,000 406,000 372,000 385,000 279,000 556,000 500,000 446,000 388,000 336,000 279,000 223,000 170,000 58,000 27,000  101,000 332,000 604,000 391,000                          
        long-term contract liabilities
      		416,745,000 424,909,000 268,854,000 252,505,000 271,925,000 253,906,000                                                                 
        total liabilities
      		544,668,000 564,228,000 406,839,000 376,939,000 379,358,000 346,519,000 55,066,000 49,046,000 48,824,000 51,662,000 43,834,000 35,059,000 30,792,000 36,028,000 28,367,000 21,934,000 22,335,000 27,442,000 27,385,000 26,340,000 34,276,000 36,307,000 33,072,000 30,626,000 23,261,000 23,191,000 21,018,000 19,104,000 20,052,000 21,394,000 16,893,000 17,230,000 16,658,000 15,986,000 13,916,000 12,210,000 11,678,000 12,945,000 12,638,000 11,703,000 4,316,000 5,156,000 5,043,000 4,208,000 5,922,000 160,304 161,255 141,528 136,516 133,025 129,162 126,773 105,345 103,648 97,145 95,402 97,771 74,751 69,677 68,385 71,404 70,389 39,863 33,897 31,613 27,160 26,907 9,413 6,108 1,776 
        stockholders’ equity
      		                                                                      
        preferred stock, 0.0001 par value...
      		                                                                      
        common stock, 0.0001 par value...
      		9,000 9,000 9,000 9,000 8,000 8,000 8,000 8,000 8,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 7,000 6,000 6,000 5,000 5,000 5,000 5,000 4,000 4,000 4,000 3,000 3,000 3,000 3,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 1,000 1,000 1,000 500  500 500 500   500 500 500 500 500 500 500 500 500 500 500 500 500 500 500  500 500 
        additional paid-in capital
      		1,355,675,000 1,347,190,000 1,334,704,000 1,323,739,000 1,316,275,000 1,308,290,000 1,298,852,000 1,288,326,000 1,276,856,000 1,119,976,000 1,112,118,000 1,104,944,000 1,003,949,000 997,111,000 964,724,000 957,489,000 948,312,000 941,359,000 934,168,000 925,796,000 919,258,000 913,354,000 582,608,000 574,385,000 434,722,000 431,322,000 428,259,000 425,035,000 313,220,000 310,849,000 308,366,000 231,120,000 228,759,000 169,201,000 167,752,000 112,866,000 111,647,000 110,748,000 110,162,000 109,577,000 108,975,000 108,484,000 57,604,000 57,069,000 57,040,000 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 49,500 
        accumulated other comprehensive income
      		-380,000 1,024,000 918,000 711,000 974,000 764,000 1,116,000           -1,789,000 -194,000 -393,000 -82,000 46,000 224,000 557,000 561,000 331,000 332,000 161,000 18,000          11,000 45,000 11,000                              
        accumulated deficit
      		-1,247,421,000 -1,174,088,000 -1,093,089,000 -1,018,973,000 -952,851,000 -895,422,000 -876,205,000 -821,801,000 -770,964,000 -721,439,000 -678,653,000 -640,051,000 -602,877,000 -568,808,000 -535,694,000 -500,190,000 -465,421,000 -432,968,000 -400,225,000 -366,859,000 -333,196,000 -302,502,000 -276,343,000 -252,574,000 -232,087,000 -212,877,000 -195,012,000 -178,620,000 -163,677,000 -149,737,000 -133,640,000 -118,633,000 -103,894,000 -89,290,000 -78,542,000 -69,209,000 -61,389,000 -53,856,000 -46,509,000 -39,583,000 -32,922,000 -26,296,000 -19,822,000 -13,732,000 -8,147,000                          
        total stockholders’ equity
      		107,883,000 174,135,000 242,542,000 305,486,000 364,406,000 413,640,000 423,771,000 466,070,000 505,084,000 397,273,000 429,937,000 459,678,000 395,183,000 420,278,000    506,609,000                                                     
        total liabilities and stockholders’ equity
      		652,551,000 738,363,000 649,381,000 682,425,000 743,764,000 760,159,000 478,837,000 515,116,000 553,908,000 448,935,000 473,771,000 494,737,000 425,975,000 456,306,000    534,051,000                                                     
        current portion of long-term debt
      		  4,337,000 3,112,000 1,921,000 2,607,000 1,715,000 847,000             3,000,000 3,000,000 2,500,000 1,750,000 1,000,000 250,000     2,834,000 2,813,000 2,294,000 1,531,000 1,024,000 500,000                                   
        commitments and contingencies
      		                                                                      
        receivable from contracts with collaborators
      		  35,936,000 4,574,000 48,746,000                                                                  
        accounts payable and accrued expenses
      		  66,788,000 52,931,000 45,094,000 49,953,000 36,966,000 31,137,000 30,903,000 33,757,000 25,843,000 21,554,000 16,901,000 21,739,000 22,441,000 15,583,000  22,455,000 21,926,000 21,290,000 22,139,000 23,024,000 19,205,000 16,801,000 13,554,000 15,314,000 12,865,000 10,878,000 11,782,000 13,385,000 9,817,000 9,330,000 8,724,000 8,284,000 6,196,000 4,179,000 3,688,000 4,681,000 4,184,000 3,330,000 3,115,000 4,118,000 3,654,000 2,492,000 4,469,000                11,404 10,389 4,863 8,897 6,613 2,160 1,907 9,413 6,108 1,776 
        current assets:
      		                                                                      
        current liabilities:
      		                                                                      
        stockholders’ equity:
      		                                                                      
        accumulated other comprehensive loss
      		       -463,000 -816,000 -1,271,000 -3,535,000 -5,222,000 -5,896,000 -8,032,000 -9,416,000 -7,815,000 -6,648,000             -131,000 -123,000 -93,000 -68,000 -49,000 -14,000 -22,000 -19,000 -18,000                                 
        restricted cash
      		           210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000 210,000                                              
        liabilities and stockholders' equity
      		                                                                      
        stockholders' equity:
      		                                                                      
        total stockholders' equity
      		              419,621,000 449,491,000 476,250,000  533,756,000 558,551,000 585,987,000 610,905,000 306,495,000 322,374,000 203,201,000 218,781,000 233,584,000 246,581,000 149,565,000 160,985,000 174,607,000 112,397,000 124,800,000 79,865,000 89,199,000 43,637,000 50,241,000 56,876,000 63,666,000 70,041,000 76,066,000 82,103,000 37,784,000 43,324,000 48,894,000                 -40,991   -18,596 -11,129 -5,632 -2,005 1,400 10,508 
        total liabilities and stockholders' equity
      		              447,988,000 471,425,000 498,585,000  561,141,000 584,891,000 620,263,000 647,212,000 339,567,000 353,000,000 226,462,000 241,972,000 254,602,000 265,685,000 169,617,000 182,379,000 191,500,000 129,627,000 141,458,000 95,851,000 103,115,000 55,847,000 61,919,000 69,821,000 76,304,000 81,744,000 80,382,000 87,259,000 42,827,000 47,532,000 54,816,000                 29,398   13,017 16,031 21,275 7,408 7,508 12,284 
        accrued expenses
      		                14,112,000                             8,900 3,462 2,925 7,000 5,500 3,000 2,750 1,500 5,500 1,500 1,500 1,500 5,500 7,180 6,185           
        operating lease liabilities, long-term
      		                      6,023,000 6,019,000                                               
        accounts receivable, related party
      		                        31,000 30,000 47,000 111,000 179,000 224,000 232,000 230,000 257,000 216,000 209,000 304,000 341,000 295,000 261,000 286,000 406,000 430,000 379,000 372,000 349,000                          
        other long-term assets, related party
      		                          137,000 194,000 259,000            5,000 5,000 5,000 5,000 5,000                          
        accounts payable and accrued expenses, related party
      		                          247,000 354,000 361,000 230,000 254,000 437,000 333,000 216,000 342,000 397,000 428,000 770,000 1,088,000 1,054,000 1,195,000 937,000  1,112,000                           
        other long-term liabilities, related party
      		                            24,000                                          
        long-term liabilities
      		                                        6,000                              
        convertible notes payable, related party, current
      		                                                                      
        convertible notes payable, related party
      		                                                                      
        stockholders' equity
      		                                                                      
        accumulated comprehensive loss
      		                                         -87,000  -14,000                           
        accounts payable, related party
      		                                          1,057,000  1,062,000                          
        accumulated comprehensive gain
      		                                          1,000                            
        cash
      		                                            53,571,000                          
        prepaid expenses
      		                                            707,000    625 2,500 4,375  1,125 3,500 5,875 6,250 625 2,500 4,375 6,250 625 2,500 5,625  1,875 3,000 4,500   3,000 
        liabilities and stockholders' deficit
      		                                                                      
        accrued interest
      		                                             24,002 22,111 20,448 18,803 17,175 15,512 13,848 12,555 11,298 10,012 8,727 7,455 6,324             
        notes payable, stockholders
      		                                             125,000 125,000 110,000 110,000 110,000 110,000 110,000 85,000 85,000 85,000 85,000 85,000 60,000 60,000 60,000 60,000 60,000 35,000 25,000 25,000 25,000 25,000    
        stockholders' deficit
      		                                                                      
        deficit accumulated during the development stage
      		                                             -204,691  -186,610 -179,723 -173,957 -164,207 -158,068 -151,319 -145,346 -135,684 -129,671 -123,403 -118,031 -109,147 -102,880 -96,145 -90,991 -78,478 -72,902 -68,596 -61,129 -55,632 -52,005 -48,600 -39,492 
        total stockholders' deficit
      		                                             -154,691  -136,610 -129,723 -123,957 -114,207 -108,068 -101,319 -95,346 -85,684 -79,671 -73,403 -68,031 -59,147 -52,880 -46,145  -28,478 -22,902       
        total liabilities and stockholders' deficit
      		                                             5,613 18,217 4,918 6,793 9,068 14,955 18,705 4,026 8,302 11,461 15,731 24,368 6,720 10,530 15,505 25,259  11,385 10,995       
        no shares issued and outstanding
      		                                                                      
        5,000,000 shares issued and outstanding
      		                                              500    500 500                500   
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-08-22 2015-06-30 2015-03-31 2014-03-31 2013-12-31 2013-11-16 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2009-06-30 2009-03-31 
                                                                  
          operating activities
        		                                                          
          net loss
        		-73,333,000 -80,999,000 -74,116,000 -66,122,000 -57,429,000 -19,217,000 -54,404,000 -50,837,000 -49,525,000 -42,786,000 -38,602,000 -37,174,000 -34,069,000 -33,114,000 -35,504,000 -34,769,000 -32,453,000 -32,743,000 -33,366,000 -33,663,000 -30,694,000 -26,159,000 -23,769,000 -20,487,000 -19,210,000 -17,865,000 -16,392,000 -14,943,000 -13,940,000 -16,097,000 -15,007,000 -14,739,000 -14,604,000 -10,748,000 -9,333,000 -7,820,000 -7,533,000 -7,347,000 -6,926,000 -6,661,000 -6,626,000 -6,474,000  -5,585,000 -4,476,000              
          adjustments to reconcile net loss to net cash from operating activities:
        		                                                          
          share-based compensation expense
        		8,416,000 11,352,000 10,965,000 6,949,000 7,842,000 8,631,000 8,324,000 8,430,000 8,512,000 7,167,000 7,090,000 6,987,000 6,838,000 6,805,000 6,355,000 6,508,000 6,650,000 6,397,000 6,114,000 5,993,000 5,075,000 3,742,000 3,360,000 2,552,000 3,153,000 2,439,000 2,452,000 2,249,000 2,269,000 1,716,000 2,523,000 2,236,000 2,179,000 1,446,000 1,175,000 1,030,000 894,000 586,000 584,000 429,000 490,000 596,000 534,000 485,000 644,000              
          amortization of premium and accretion of discounts on short-term investments
        		-900,000 -1,382,000 -1,924,000 -2,520,000 -2,662,000                                                      
          depreciation expense
        		355,000 403,000 164,000 224,000 241,000 204,000 208,000 202,000 234,000 214,000 216,000 213,000 206,000 206,000 193,000 183,000 177,000 166,000 160,000 124,000 108,000 108,000 74,000       0 1,000 4,000 5,000 7,000 7,000 8,000 8,000 8,000 8,000 7,000 8,000 7,000 7,000 3,000 3,000              
          non-cash interest expense
        		106,000 103,000 141,000 138,000 133,000 140,000 134,000 127,000 122,000 119,000 122,000 121,000 115,000     0 0           17,000 53,000 57,000 57,000 56,000 30,000 16,000 16,000 15,000 16,000                    
          changes in operating assets and liabilities
        		                                                          
          accounts receivable
        		-544,000                                                          
          inventory
        		-430,000                                                          
          prepaid expenses and other current assets
        		-562,000 2,890,000 -10,289,000 -7,512,000 -1,039,000 -9,542,000 357,000 2,464,000 -2,189,000 -2,534,000 800,000 1,883,000 -2,109,000 1,352,000 912,000 -2,569,000 -2,630,000 1,131,000 678,000 694,000 -2,860,000 -474,000 130,000 1,115,000 -1,482,000 -547,000 -396,000 -288,000 146,000 825,000 -256,000 -402,000 -624,000 -12,000 278,000 -53,000 -409,000 161,000 159,000 158,000 -510,000 -6,000 134,000                
          operating lease right-of-use and other long-term assets
        		689,000 -558,000 -2,883,000 -1,169,000 -1,753,000 685,000 -508,000 539,000 231,000 -1,463,000 276,000 317,000 185,000                                              
          accounts payable
        		2,026,000                                                          
          accrued expenses and other current liabilities
        		-16,216,000                                                          
          operating lease liabilities
        		3,778,000                                                          
          other long-term liabilities
        		204,000 118,000 297,000 369,000 259,000 235,000 210,000 144,000 169,000 62,000 29,000 33,000 13,000 17,000 83,000 -37,000 121,000 19,000 61,000 -146,000 46,000 50,000 234,000 -130,000 59,000 83,000 57,000 54,000 16,000 66,000 56,000 54,000 58,000 52,000 57,000 -38,000 147,000 113,000 30,000   1,000 -1,000                
          contract liabilities
        		-9,443,000 156,288,000 15,664,000 -10,831,000 34,594,000                                                      
          net cash from operating activities
        		-85,854,000 117,273,000 -80,627,000 -28,777,000 -71,927,000 269,131,000 -43,440,000 -42,530,000 -48,844,000 -34,308,000 -29,027,000 -25,617,000 -35,872,000 -26,530,000 -21,010,000 -30,341,000 -32,181,000 -23,366,000 -24,594,000 -28,074,000 -28,517,000 -18,308,000 -16,966,000 -14,734,000 -19,822,000 -13,933,000 -12,145,000 -14,431,000 -14,251,000 -10,211,000 -13,001,000 -12,592,000 -12,851,000 -7,474,000 -6,235,000 -6,110,000 -8,622,000 -6,738,000 -5,472,000 -5,825,000 -7,314,000 -5,605,000 -4,430,000 -3,767,000 -4,123,000 -400 -4,012            
          capital expenditures
        		-128,000 -2,321,000 -2,567,000 -1,458,000 -292,000 -372,000 0 -16,000 -84,000 -16,000 -20,000 -96,000 -36,000 -12,000 -381,000 -184,000 -49,000 -102,000 -723,000 -291,000 -31,000 -275,000 -665,000 -720,000 -511,000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  -15,000 -22,000 -17,000 -10,000 0 0            
          free cash flows
        		-85,982,000 114,952,000 -83,194,000 -30,235,000 -72,219,000 268,759,000 -43,440,000 -42,546,000 -48,928,000 -34,324,000 -29,047,000 -25,713,000 -35,908,000 -26,542,000 -21,391,000 -30,525,000 -32,230,000 -23,468,000 -25,317,000 -28,365,000 -28,548,000 -18,583,000 -17,631,000 -15,454,000 -20,333,000 -13,933,000 -12,145,000 -14,431,000 -14,251,000 -10,211,000 -13,001,000 -12,592,000 -12,851,000 -7,474,000 -6,235,000 -6,110,000 -8,622,000 -6,738,000 -5,472,000 -5,825,000  -5,620,000 -4,452,000 -3,784,000 -4,133,000 -400 -4,012            
          investing activities
        		                                                          
          purchases of short-term investments
        		-171,601,000 -239,775,000 -138,499,000 -114,600,000 -268,714,000                                                      
          maturities of short-term investments
        		147,498,000 177,500,000 235,032,000 174,999,000 167,597,000                                                      
          purchases of property and equipment
        		-128,000 -2,321,000 -2,567,000 -1,458,000 -292,000 -372,000 0 -16,000 -84,000 -16,000 -20,000 -96,000 -36,000 -12,000 -381,000 -184,000 -49,000 -102,000 -723,000 -291,000 -31,000 -275,000 -665,000 -720,000 -511,000                 -15,000 -22,000 -17,000 -10,000              
          net cash from investing activities
        		-24,231,000 -64,596,000 93,966,000 58,941,000 -101,409,000 -94,955,000 45,535,000 43,167,000 -95,337,000 42,195,000 8,559,000 -46,326,000 11,129,000 -47,318,000 71,810,000 33,097,000 -24,962,000 74,061,000 22,545,000 -37,221,000 -186,220,000 -60,190,000 -45,520,000 -21,687,000 27,461,000 -15,257,000 -55,752,000 8,876,000 15,808,000 4,618,000 -58,061,000 3,857,000 -29,714,000 -4,091,000 -36,294,000 7,433,000 9,534,000 9,680,000 143,000 -5,842,000 8,197,000 -40,448,000 -3,891,000 -26,277,000 -10,000              
          financing activities
        		                                                          
          proceeds from issuance of stock under equity plans
        		69,000 1,135,000 0 515,000 143,000 807,000 2,202,000 3,040,000 2,555,000 691,000 84,000   567,000 880,000                                            
          net cash from financing activities
        		69,000 1,135,000 0 515,000 143,000 806,000 2,202,000 3,040,000 148,369,000 691,000 84,000   34,713,000 880,000 2,669,000 303,000 794,000 2,258,000 -6,566,000 79,000 327,036,000 4,683,000 137,368,000 247,000 583,000 559,000 109,857,000 102,000 1,144,000 73,972,000 -125,000 57,650,000 -338,000 53,711,000 189,000 5,000 0 0   50,281,000 -252,000 -3,739,000 56,580,000  0 0    25,000 0   0   
          net decrease in cash and cash equivalents
        		-110,016,000                                                          
          cash and cash equivalents at beginning of period
        		149,099,000 0 0 0 224,462,000 0 0 0 37,318,000 0                0 0 0 16,119,000 0 0 0 11,433,000 0 0 0 9,725,000 0 0 0 15,443,000 0 0    0            
          cash and cash equivalents at end of period
        		39,083,000 53,812,000 13,339,000 30,679,000 51,269,000 174,982,000 4,297,000 3,677,000 41,506,000 8,578,000                -28,607,000 -67,338,000 104,302,000 17,778,000 -4,449,000 2,910,000 -8,860,000 26,518,000 -11,903,000 11,182,000 1,512,000 10,642,000 2,942,000 -5,329,000 -4,214,000 16,326,000 4,228,000 -8,573,000    -4,012            
          changes in operating assets and liabilities:
        		                                                          
          proceeds from issuances of common stock and pre-funded warrants, net of offering costs
        		                                                          
          net increase in cash and cash equivalents
        		 53,812,000 13,339,000 30,679,000 -173,193,000 174,982,000 4,297,000 3,677,000 4,188,000                 -28,607,000 -67,338,000 104,302,000 1,659,000 -4,449,000 2,910,000 -8,860,000 15,085,000 -11,903,000 11,182,000 1,512,000 917,000 2,942,000 -5,329,000 -4,214,000 883,000 4,228,000 -8,573,000   -400 -4,012 -8,125 -3,100 -15,379 -2,264 24,644 -3,506 -5,235 -147 -3,744 9,367 -100 
          supplemental disclosure of cash flow information
        		                                                          
          interest paid
        		                                 161,000 161,000 157,000 148,000                      
          accounts payable and accrued expenses
        		  12,716,000 7,525,000 -5,427,000 12,702,000 5,676,000 -50,000 -3,128,000 7,646,000 3,932,000 4,113,000 -5,364,000 -1,560,000 6,350,000 -341,000 -5,251,000 31,000 139,000 -1,236,000 -1,452,000 3,684,000 2,530,000 1,854,000 -2,391,000 1,804,000 2,176,000 -1,204,000 -1,920,000 3,565,000 723,000 374,000 440,000 2,433,000 1,675,000 586,000 -1,088,000 497,000 856,000 215,000 -1,097,000 251,000 1,179,000 1,292,000 90,000              
          receivable from contracts with collaborators
        		  -31,362,000 44,172,000 -46,686,000                                                      
          proceeds from issuance of common stock and pre-funded warrants, net of offering costs
        		      0 0 145,814,000  0                                                
          supplemental disclosure of non-cash investing activities
        		                                                          
          unpaid amounts related to purchases of property and equipment
        		                                                          
          proceeds from long-term debt
        		                                                          
          payment of fees related to issuance of long-term debt
        		                                                          
          supplemental non-cash disclosures
        		                                                          
          warrants issued in connection with debt facility
        		                                                          
          amortization of premium and accretion of discounts on marketable securities
        		      -3,437,000 -3,549,000 -3,270,000 -2,733,000 -2,890,000 -2,110,000 -1,687,000 -654,000 370,000 794,000 1,100,000 1,216,000 1,188,000 1,137,000 850,000         -636,000 -596,000 -428,000 -275,000                          
          purchases of marketable securities
        		      -61,729,000 -161,673,000 -195,063,000 -99,689,000 -96,671,000 -139,629,000 -73,835,000 -106,123,000 -56,953,000 -56,179,000 -51,400,000 -16,337,000 -76,232,000 -129,930,000 -223,158,000 -128,020,000 -96,125,000 -85,544,000 -11,274,000 -30,747,000 -94,952,000 -51,024,000 -50,848,000 -33,982,000 -96,611,000 -30,643,000 -76,207,000 -21,381,000 -59,894,000 -8,817,000 -10,543,000 -15,220,000 -17,762,000 -19,442,000 -4,003,000 -46,433,000 -3,869,000                
          maturities of marketable securities
        		      107,264,000 204,856,000 99,810,000 141,900,000 105,250,000 93,399,000 85,000,000 58,817,000 129,144,000 89,460,000 26,487,000 90,500,000 99,500,000 93,000,000 36,969,000         38,600,000 38,550,000 34,500,000 46,493,000 17,290,000 23,600,000 16,250,000 20,077,000 24,900,000 17,905,000 13,600,000 12,200,000                  
          loss from extinguishment of debt
        		                                                          
          repayment of long-term debt
        		                 0 0 -6,500,000 -750,000         -250,000 -750,000                            
          payment of fees related to extinguishment of debt
        		                 0 0                                        
          net decrease in cash, cash equivalents
        		                                                          
          supplemental disclosure of cash flow information:
        		                                                          
          supplemental non-cash disclosures:
        		                                                          
          net decrease in cash, cash equivalents and restricted cash
        		           22,065,000 -24,743,000   5,425,000 -56,840,000                                          
          cash, cash equivalents and restricted cash at beginning of period
        		           0 52,012,000 0 0 0 90,882,000 0 0 0 325,703,000 0 0 0 26,135,000                                  
          cash, cash equivalents and restricted cash at end of period
        		           22,065,000 27,269,000 -39,135,000 51,680,000 5,425,000 34,042,000 51,489,000 209,000 -71,861,000 111,045,000 248,538,000 -57,803,000 100,947,000 34,021,000                                  
          proceeds from issuances of common stock
        		                                                          
          net increase in cash, cash equivalents and restricted cash
        		             -39,135,000    51,489,000 209,000 -71,861,000 -214,658,000 248,538,000 -57,803,000 100,947,000 7,886,000                                  
          loss on extinguishment of debt
        		                  0                                        
          other long-term assets
        		              231,000 -110,000 105,000 417,000 432,000 -1,588,000 410,000 373,000 299,000 373,000 160,000 133,000 71,000 -82,000 -239,000 -149,000 -313,000 121,000 -163,000 -388,000 -88,000 171,000 -288,000 -429,000 -274,000 -23,000 74,000 124,000 -159,000                
          proceeds from issuance of stock under equity incentive plan
        		                303,000                                          
          proceeds from exercises of stock options and purchases under employee stock purchase plan
        		                 794,000 2,258,000                                        
          proceeds from issuance of common stock
        		                      -180,000    -213,000    74,520,000 0 57,650,000 -4,000 53,524,000       50,284,000 -255,000 -3,739,000 51,580,000              
          proceeds from exercise of stock options
        		                    829,000    247,000    102,000  202,000   10,000 187,000 30,000 5,000                      
          maturities and sales of marketable securities
        		                     68,105,000 51,270,000 64,577,000 39,246,000 15,490,000 39,200,000 59,900,000 66,656,000                              
          proceeds from issuance of long-term debt
        		                                     0 0                    
          amortization of premium and accretion of discount on marketable securities
        		                      176,000 -24,000 -110,000  -128,000 -319,000 -540,000                              
          proceeds from exercise of stock options and purchases under employee stock purchase plan
        		                      4,863,000   604,000 772,000                                
          accounts receivable, related party
        		                        -1,000 17,000 64,000 84,000 45,000 8,000 -2,000 27,000 -41,000 -7,000 95,000 37,000 -46,000 -34,000 25,000 120,000 24,000 -51,000 -7,000 -24,000 -318,000              
          loss on debt extinguishment
        		                                                          
          payment of fee related to long-term debt
        		                                                          
          other long-term assets, related party
        		                          57,000 49,000 57,000                              
          accounts payable and accrued expenses, related party
        		                          -106,000 -31,000 -145,000 -24,000 -183,000 104,000 117,000 -126,000 -55,000 -31,000 -342,000 -318,000 34,000 -141,000 258,000                  
          amortization of discount on marketable securities
        		                                  -76,000 -16,000 19,000 10,000 16,000 38,000 65,000 67,000 67,000                
          non-cash license fee expense
        		                                         0 0 0 500,000              
          change in value of derivative liability
        		                                         0 -39,000                
          non-cash interest expense, related party
        		                                                          
          proceeds from issuance of convertible notes
        		                                                          
          proceeds from issuance of convertible notes, related party
        		                                                          
          conversion of convertible notes and related accrued interest to common stock
        		                                         0 0 0 4,327,000              
          conversion of convertible notes and related accrued interest to common stock, related party
        		                                         0 0 0 3,288,000              
          proceeds from issuance of convertible notes payable
        		                                          0 0 5,000,000              
          proceeds from issuance of convertible notes payable, related party
        		                                                          
          proceeds from issuance of restricted stock awards
        		                                                          
          supplemental disclosure of non-cash financing activities:
        		                                                          
          financing costs included in accounts payable and accrued expenses
        		                                           -3,282,000 3,535,000              
          non-cash accrued interest expense
        		                                         0 0 0 37,000              
          non-cash accrued interest expense, related party
        		                                         0                 
          long-term liabilities
        		                                                          
          accrued interest, related party
        		                                                          
          accounts payable, related party
        		                                            927,000              
          proceeds from issuance of notes payable, related party
        		                                                          
          net income
        		                                              -9,750            
          adjustments to reconcile net income to net cash from operating activities:
        		                                                          
          non-cash accrued interest expense, related parties
        		                                           1,000 41,000              
          adjustments to reconcile net loss to net cash used in operating activities:
        		                                                          
          prepaid expenses
        		                                            -664,000              
          other liabilities
        		                                            -907,000              
          net increase in cash
        		                                            52,447,000              
          cash at beginning of period
        		                                            1,124,000              
          cash at end of period
        		                                            53,571,000              
          net cash (used in) investing activities
        		                                                          
          decrease (increase) in prepaid expenses
        		                                                          
          increase in accounts payable
        		                                              -300            
          increase in accrued interest
        		                                              1,663            
          increase in accrued expenses
        		                                                          
          proceeds from notes payable, stockholders
        		                                              0            
          payments on notes payable, stockholders
        		                                                          
          deferred tax asset:
        		                                                          
          capitalized formation costs
        		                                                          
          net operating income carryforward
        		                                                          
          valuation allowance
        		                                                          
          net deferred tax asset recognized
        		                                                          
          increase in prepaid expenses
        		                                                          
          1.
        		                                                          
          net cash (used in) operating activities
        		                                                -3,100 -15,379 -2,264 -356 -3,506 -15,235 -147 -3,744 -15,633 -100